Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,902 | 15,044 | 20,421 | 61,661 | 83,293 |
| Marketable Securities | 138,395 | 194,645 | 241,851 | 249,127 | 113,524 |
| Receivables | 2,913 | 4,406 | 4,482 | 4,825 | 10,597 |
| Inventories | 4,755 | 2,142 | 2,112 | 1,948 | 2,149 |
| TOTAL | $198,360 | $220,191 | $273,150 | $321,995 | $214,021 |
| Non-Current Assets | |||||
| PPE Net | 16,299 | 16,772 | 17,244 | 17,687 | 18,167 |
| Intangibles | 95,104 | 95,545 | 95,987 | 96,428 | 96,870 |
| Other Non-Current Assets | 429 | 429 | 432 | 429 | 429 |
| TOTAL | $111,832 | $112,746 | $113,663 | $114,544 | $115,466 |
| Total Assets | $310,192 | $332,937 | $386,813 | $436,539 | $329,487 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,115 | 12,896 | 13,517 | 14,094 | N/A |
| Accounts payable and accrued liabilities | 51,480 | 50,451 | 66,553 | 38,762 | 52,628 |
| Accrued Expenses | 13,794 | 12,865 | 12,863 | 12,282 | 12,729 |
| TOTAL | $68,506 | $81,336 | $100,370 | $105,489 | $128,728 |
| Non-Current Liabilities | |||||
| Long Term Debt | 243,830 | 232,198 | 231,879 | 231,576 | 85,512 |
| Deferred Revenues | 2,117 | 5,124 | 7,437 | 40,351 | 48,738 |
| Other Non-Current Liabilities | 252 | 265 | 279 | 292 | 303 |
| TOTAL | $271,087 | $256,672 | $260,249 | $262,785 | $122,383 |
| Total Liabilities | $339,593 | $338,008 | $360,619 | $368,274 | $251,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,925 | 105,879 | 105,832 | 105,592 | 105,588 |
| Common Shares | 106 | 106 | 106 | 106 | 106 |
| Retained earnings | -1,471,485 | -1,443,973 | -1,409,267 | -1,365,241 | -1,353,026 |
| Other shareholders' equity | 53 | -94 | -270 | -126 | 33 |
| TOTAL | $-29,401 | $-5,071 | $26,194 | $68,265 | $78,376 |
| Total Liabilities And Equity | $310,192 | $332,937 | $386,813 | $436,539 | $329,487 |